FDA NDC Directory · JSON-LD · Markdown

BKEMV

NDC 55513-180 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameeculizumab-aeeb
Labeler / ManufacturerAmgen Inc
Marketing categoryBiologic License Application · App BLA761333
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsECULIZUMAB (300 mg/30mL)
Marketing started20250301
Package count1

External sources

Source: openFDA. Public-domain (CC0).